Solid Form Selection and Process Development of KO-947 Drugs

Preformulation and process scientists from WuXi STA and our partner Kura Oncology published this paper on solid form screening that achieved aqueous solubility enhancement through salt form selection. The team also established a manufacturing process for successful clinical trial material production.

View now